Neuromedin U as a Novel Mechanism Underlying Cocaine Addiction
Neuromedin U 作为可卡因成瘾的新机制
基本信息
- 批准号:8446059
- 负责人:
- 金额:$ 11.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAddressAmericanAnimalsAreaBehavioralBehavioral ResearchBiologicalBiologyBrainChronicCocaineCocaine AbuseCocaine DependenceCocaine UsersDataDependovirusDevelopmentDiseaseEatingExhibitsFDA approvedFOS geneFoodGoalsHyperactive behaviorIndividualIndividual DifferencesInjection of therapeutic agentIntakeLeadLinkMediatingMessenger RNAMethodologyMolecularMolecular BiologyMotor ActivityNeurobiologyNeuromedin UNeuronsNeuropeptidesNucleus AccumbensPathway interactionsPeptidesPeripheralPharmaceutical PreparationsPharmacological TreatmentProcessRNA InterferenceRattusRegulationRelative (related person)ResearchResistanceRewardsRoleSignal TransductionSubstance abuse problemSystemUnited StatesVentral Tegmental Areaaddictionbasebehavioral sensitizationcocaine exposurecocaine usedrug addiction therapydrug of abusedrug rewardinnovationinsightmRNA Expressionneuroadaptationneurobehavioralneuromedin U receptornew therapeutic targetnovelpublic health relevancerelating to nervous systemresilienceresponseviral RNA
项目摘要
DESCRIPTION (provided by applicant): Safe and effective approaches for the treatment of cocaine addiction are needed to address the tremendous burden of substance abuse disorders. An expanded mechanistic appreciation of the molecular, neural, and behavioral bases of reward is needed to identify integral pharmacotherapeutic targets for addiction. Interestingly, over 400,000 Americans are active cocaine users but are not considered cocaine dependent. These individuals have an underlying resilient neurobiology which makes them resistant to the development of addiction to cocaine. Studying this "neurobiology of resilience" may provide insight into the molecular, neural, and behavioral basis of addiction and lead to novel pharmacotherapeutic targets for cocaine addiction. An innovative prospect in this regard is neuromedin U (NMU), a highly conserved neuropeptide which has been shown to inhibit intake of food, a natural reward. These effects of NMU may be due to actions in the ventral tegmental area (VTA), the origin of the mesoaccumbens system. Little is known about the involvement of NMU in mesoaccumbens circuit, although recent data demonstrate that NMU administration increases neuronal activity in a terminal area of this circuit, the nucleus accumbens. Preliminary data indicates that expression is increased in the VTA in response to acute or chronic cocaine, a response which shows high levels of individual differences, with some animals in the range of controls while others are fivefold higher than controls. Also, we found that peripheral injection o NMU can block behavioral sensitization to cocaine. The goal of the present proposal is to explore NMU signaling in the VTA as a key mechanism that underlies behavioral responses to cocaine. To this end, it will be determined if changes in expression of NMU in the VTA can predict the magnitude of behavioral responses to cocaine. In addition, we seek to demonstrate a role for NMU in the behavioral effects of cocaine via use of RNAi-mediated knockdown of NMU in the VTA followed by assessment of locomotor sensitization to cocaine. Overall, linking NMU signaling in the VTA with the behavioral effects of cocaine will promote the idea that NMU signaling underlies behavioral responses to drugs of abuse, and support its potential as a novel therapeutic target to treat addiction.
描述(由申请人提供):需要安全有效的可卡因成瘾治疗方法来解决药物滥用障碍的巨大负担。需要对奖赏的分子、神经和行为基础进行扩展的机制性评价,以确定成瘾的整体药物靶点。有趣的是,超过40万美国人是活跃的可卡因使用者,但不被认为是可卡因依赖者。这些人具有潜在的弹性神经生物学,使他们对可卡因成瘾的发展具有抵抗力。研究这种“复原力的神经生物学”可能会深入了解成瘾的分子,神经和行为基础,并导致可卡因成瘾的新药物靶点。在这方面的一个创新的前景是神经介肽U(NMU),它是一种高度保守的神经肽,已被证明可以抑制食物的摄入,这是一种自然的奖励。NMU的这些作用可能是由于腹侧被盖区(VTA)的作用,腹侧被盖区是中脑系统的起源。很少有人知道NMU在mesoebens电路的参与,虽然最近的数据表明,NMU管理增加神经元的活动,在该电路的终端区域,核神经元。初步数据表明,在VTA中的表达增加,以响应急性或慢性可卡因,这种响应显示出高水平的个体差异,一些动物在对照范围内,而另一些动物比对照高五倍。此外,我们发现外周注射NMU可以阻断可卡因的行为敏化。本提案的目标是探索VTA中的NMU信号传导作为对可卡因的行为反应的关键机制。为此,将确定VTA中NMU表达的变化是否可以预测对可卡因的行为反应的程度。此外,我们试图证明NMU在可卡因的行为效应中的作用,通过使用RNAi介导的敲低VTA中的NMU,然后评估可卡因的运动敏感性。总的来说,将VTA中的NMU信号传导与可卡因的行为效应联系起来将促进NMU信号传导是对滥用药物的行为反应的基础的想法,并支持其作为治疗成瘾的新治疗靶点的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan Dean Hommel其他文献
Jonathan Dean Hommel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan Dean Hommel', 18)}}的其他基金
Chronic alcohol regulates circuitry structure and demand for alcohol
慢性酒精调节回路结构和对酒精的需求
- 批准号:
10373655 - 财政年份:2022
- 资助金额:
$ 11.62万 - 项目类别:
Chronic alcohol regulates circuitry structure and demand for alcohol
慢性酒精调节回路结构和对酒精的需求
- 批准号:
10684127 - 财政年份:2022
- 资助金额:
$ 11.62万 - 项目类别:
Hypothalamic-Striatal Control of Motivation for Obesogenic Food
下丘脑-纹状体对致胖食物动机的控制
- 批准号:
10027208 - 财政年份:2020
- 资助金额:
$ 11.62万 - 项目类别:
Integration of Hypothalamic and Limbic Pathways to Regulate Motivation for Food
整合下丘脑和边缘通路来调节食物动机
- 批准号:
9910392 - 财政年份:2016
- 资助金额:
$ 11.62万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 11.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 11.62万 - 项目类别:
Standard Grant